Michael Ouk

Relationships between memory decline and the use of metformin or DPP4 inhibitors in people with type 2 diabetes with normal cognition or Alzheimer's disease, and the role <i>APOE</i> carrier status

Che‐Yuan Wu, Michael Ouk, Yuen Yan Wong et al. · Alzheimer s & Dementia · 2020 · 93 citations · Full text

Medicine, Neurology, Pharmacology +14

The use of angiotensin-converting enzyme inhibitors vs. angiotensin receptor blockers and cognitive decline in Alzheimer’s disease: the importance of blood-brain barrier penetration and APOE ε4 carrier status

Michael Ouk, Che‐Yuan Wu, Jennifer S. Rabin et al. · Alzheimer s Research & Therapy · 2021 · 69 citations · Full text

Medicine, Neurology, Pharmacotherapy +17

A peripheral neutrophil-related inflammatory factor predicts a decline in executive function in mild Alzheimer’s disease

Kritleen K. Bawa, Saffire H. Krance, Nathan Herrmann et al. · Journal of Neuroinflammation · 2020 · 67 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Associations between brain amyloid accumulation and the use of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers

Michael Ouk, Che‐Yuan Wu, Jennifer S. Rabin et al. · Neurobiology of Aging · 2020 · 33 citations

Life Sciences, Neurology, Pharmacology +15

Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer’s dementia

Lisa Y. Xiong, Michael Ouk, Che‐Yuan Wu et al. · Alzheimer s Research & Therapy · 2021 · 30 citations · Full text

Medicine, Neurology, Pharmacology +17